Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

The data that comes out of those two US RBL's and the one prepring of the peer reviewed article is what will help the FDA approve the upcoming trial against covid.

That same data will up the chances of a good grant to the company moving forward.

The timing of all this should come about the same time as IV drug is manufactured.

The only grant I expect to see near term is that applied for by one of the RBL's for more extensive testing of Brilacidin against a variety of different viruses.

I expect a good move with trial start since most don't expect it to happen.







Message in reply to:

Is the next PR reporting the latest RBL data the straw that breaks the camel's back as to getting Brilacidin in the spotlight of media and governmental attention (as say perhaps a mention that it the only TRUE treatment "cure" coming down the pike)? I would like to think so but to date hasn't worked out that way.

I still firmly believe we need some serious grant money from some source for the general public/world of medicine/etc to take IPIX seriously and finally get the science of Brilacidin known to the general public.

Now coupling such a nice sized grant with RBL data to show this is about the first such grant going to a truly deserving drug, and not one foisted on the public to pay off lobbying payola, that both kills CV19 prior to infection and after being infected to a startlingly effective degree, that would get the attention of America IMO.

At this point in time, the peer review article is just so much noise as by the time it gets disseminated Brilacidin will already be in a human trial and actual patient results will top professional opinion IMO.